vimarsana.com
Home
Live Updates
Afimetoran - Breaking News
Pages:
Latest Breaking News On - Afimetoran - Page 1 : vimarsana.com
Afimetoran Shown to be Safe, Well-Tolerated for Patients with Cutaneous Lupus Erythematosus
This new late-breaking data presented at ACR 2023 was the first clinical evidence indicating efficacy of afimetoran for those with cutaneous lupus erythematosus (CLE).
California
United-states
San-diego
Fareeda-hosein
Bristol-myers-squibb
American-college-of-rheumatology
American-college
With-lupus-erythematosus
Bristol-myers
Severity-index-activity
Afimetoran
Lupus
Afimetoran Shown to be Safe, Well-Tolerated for Patients with Cutaneous Lupus Erythematosus
This new late-breaking data presented at ACR 2023 was the first clinical evidence indicating efficacy of afimetoran for those with CLE.
California
United-states
San-diego
Fareeda-hosein
Bristol-myers-squibb
American-college-of-rheumatology
American-college
Bristol-myers
Severity-index-activity
Late-breaking
Cutaneous-lupus
Afimetoran
Lupus pill moves to clinical trial in humans after success in mice
Scientists report they have begun phase II clinical trials of a lupus pill in humans after success in mice.
United-states
American
Alaric-dyckman
Bristol-myers-squibb
Glaxosmithkline
Astrazeneca
American-chemical-society
Lupus
Clinical-trials
Clinical-trial
Autoimmune-diseases
Autoimmune-disease
vimarsana © 2020. All Rights Reserved.